Shingles and Dementia Risk Study
Part of Brain & nervous system, Heart & circulation, Infections, Mental health clinical trials.
This study looks at whether the virus that causes shingles (herpes zoster) might increase the risk of dementia. Participants with a fresh shingles rash will give blood samples and attend several follow-up visits over one year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a new shingles rash that has NOT been treated with antiviral medicine.
- You can return for follow-up visits at 7 days, 1, 3, 6, and 12 months.
- You are willing to have blood drawn.
- You have not had the shingles vaccine in the last 8 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
This study tests whether the shingles vaccine can reduce the risk of developing dementia in adults 76 and older living in Finland. You would get the vaccine and then researchers will follow your health records for up to several years to see if it protects your brain.
This trial tests whether a shingles vaccine can help prevent heart attacks, strokes, and dementia in older adults. If you are 65 or older and haven't had the shingles vaccine before, you may be able to join.
This study tests a new shingles vaccine for people 40 and older. It looks at safety, how well the body responds, and whether it can prevent shingles.
This study looks at how herpes zoster (shingles) affects quality of life and the overall burden of the disease. It will include adults getting the shingles vaccine and also adults diagnosed with shingles in the past, to understand the condition better.
This trial tests a new shingles vaccine to see if it's safe and helps the body build immunity. It is for healthy adults aged 50 and older who have not had shingles before.
Hear when a new Vascular Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.